Announcements Trials
Browse Landscape

Phase

Phase 1 82Phase 1/2 43Phase 2 4Phase EARLY_PHASE1 3Phase 4 1

Status

Recruiting 4Unknown 3Terminated 3Completed 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Breast Neoplasms 305Carcinoma, Non-Small-Cell Lung 287Colorectal Neoplasms 159Prostatic Neoplasms 158Carcinoma, Hepatocellular 144Neoplasms 137Leukemia, Myeloid, Acute 131Lung Neoplasms 117Squamous Cell Carcinoma of Head and Neck 108Multiple Myeloma 104Triple Negative Breast Neoplasms 102Recurrence 101Pancreatic Neoplasms 96Stomach Neoplasms 94Ovarian Neoplasms 89Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Esophageal Neoplasms 68Uterine Cervical Neoplasms 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Melanoma 67Brain Neoplasms 67Rectal Neoplasms 64Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 58Myelodysplastic Syndromes 55Lymphoma 55Esophageal Squamous Cell Carcinoma 54

Interventions

toripalimab 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Advanced Solid Tumor × Clear all
NCT06660654 2025-10-14

A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

Daiichi Sankyo

Phase 2 Recruiting
200 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06543056 2025-07-30

A Study of ES014 in Subjects With Advanced Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
15 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06413615 2024-09-26

A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Phase 2 Recruiting
150 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06490068 2024-07-08

Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
10 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡